148 related articles for article (PubMed ID: 36584732)
1. Decision criteria for selecting essential medicines and their connection to guidelines: an interpretive descriptive qualitative interview study.
Piggott T; Moja L; Akl EA; Lavis JN; Cooke G; Kredo T; Hogerzeil HV; Huttner B; Alonso-Coello P; Schünemann H
J Clin Epidemiol; 2023 Feb; 154():146-155. PubMed ID: 36584732
[TBL] [Abstract][Full Text] [Related]
2. GRADE Concept 7: Issues and Insights Linking Guideline Recommendations to Trustworthy Essential Medicine Lists.
Piggott T; Moja L; Jenei K; Kredo T; Skoetz N; Banzi R; Trapani D; Leong T; McCaul M; Lavis JN; Akl EA; Nonino F; Iorio A; Laurson-Doube J; Huttner BD; Schünemann HJ
J Clin Epidemiol; 2024 Feb; 166():111241. PubMed ID: 38123105
[TBL] [Abstract][Full Text] [Related]
3. Quantitative evaluation of essential medicines lists: the South African case study.
Perumal-Pillay VA; Suleman F
BMC Health Serv Res; 2016 Dec; 16(1):687. PubMed ID: 27955710
[TBL] [Abstract][Full Text] [Related]
4. User-experience testing of an evidence-to-decision framework for selecting essential medicines.
Piggott T; Moja L; Garcia CAC; Akl EA; Banzi R; Huttner B; Kredo T; Lavis JN; Schünemann HJ
PLOS Glob Public Health; 2024; 4(1):e0002723. PubMed ID: 38206901
[TBL] [Abstract][Full Text] [Related]
5. Selection of essential medicines for South Africa - an analysis of in-depth interviews with national essential medicines list committee members.
Perumal-Pillay VA; Suleman F
BMC Health Serv Res; 2017 Jan; 17(1):17. PubMed ID: 28061899
[TBL] [Abstract][Full Text] [Related]
6. Global status of essential medicine selection: a systematic comparison of national essential medicine lists with recommendations by WHO.
Piggott T; Nowak A; Brignardello-Petersen R; Cooke GS; Huttner B; Schünemann HJ; Persaud N; Magrini N; Moja L
BMJ Open; 2022 Feb; 12(2):e053349. PubMed ID: 35144950
[TBL] [Abstract][Full Text] [Related]
7. Access to mifepristone, misoprostol, and contraceptive medicines in eight countries in the Eastern Mediterranean Region: descriptive analyses of country-level assessments.
Afifi M; Hemachandra N; Sikandar Q; Hajjeh R; Loi UR; Läser L; Qato D; Abdul ZS; Chikvaidze P; Abbas RAR; Al-Kinani K; Hasan H; El-Kak F; Rady A; Brngali O; Hashem M; Bezad R; Amine C; Hafid H; Afzal S; Zaidi R; Thom E; Uzma Q; Al-Masri H; Qamar ZA; Ghanem B; Ward IA; Shaar AN; Farah U; Mohamed YO; Umar AU; Eladawy M
Reprod Health; 2024 Jun; 20(Suppl 1):192. PubMed ID: 38835050
[TBL] [Abstract][Full Text] [Related]
8. Insights from the WHO and National Lists of Essential Medicines: Focus on Pediatric Diabetes Care in Africa.
Rowlands A; Ameyaw E; Rutagarama F; Dipesalema J; Majaliwa ES; Mbogo J; Ogle GD; Chanoine JP
Horm Res Paediatr; 2018; 90(2):82-92. PubMed ID: 30048982
[TBL] [Abstract][Full Text] [Related]
9. Selection of WHO-recommended essential medicines for non-communicable diseases on National Essential Medicines Lists.
Jarvis JD; Woods H; Bali A; Oronsaye E; Persaud N
PLoS One; 2019; 14(8):e0220781. PubMed ID: 31398195
[TBL] [Abstract][Full Text] [Related]
10. Essential medicines for reproductive health: developing evidence based interagency list.
Logez S; Jayasekar S; Moller H; Ahmed K; Patel MU
South Med Rev; 2011 Dec; 4(2):62-8. PubMed ID: 23093884
[TBL] [Abstract][Full Text] [Related]
11. Essential medicines for children in Armenia.
Kazaryan I; Vardanyan L
Int J Risk Saf Med; 2015; 27 Suppl 1():S43-4. PubMed ID: 26639704
[TBL] [Abstract][Full Text] [Related]
12. Essential medicines for emergency care in Africa.
Broccoli MC; Pigoga JL; Nyirenda M; Wallis L; Calvello Hynes EJ
Emerg Med J; 2018 Jul; 35(7):412-419. PubMed ID: 29627770
[TBL] [Abstract][Full Text] [Related]
13. Essential cancer medicines in the national lists of countries of the WHO South-East Asia Region: a descriptive assessment.
Chivukula MV; Tisocki K
WHO South East Asia J Public Health; 2018 Sep; 7(2):90-98. PubMed ID: 30136667
[TBL] [Abstract][Full Text] [Related]
14. Relation between opioid consumption and inclusion of opioids in 137 national essential medicines lists.
Richards GC; Aronson JK; Heneghan C; Mahtani KR; Koshiaris C; Persaud N
BMJ Glob Health; 2020 Nov; 5(11):. PubMed ID: 33173012
[TBL] [Abstract][Full Text] [Related]
15. Mapping the selection, availability, price and affordability of essential medicines for mental health conditions at a global level.
Todesco B; Ostuzzi G; Barbui C
Epidemiol Psychiatr Sci; 2022 Apr; 31():e22. PubMed ID: 35438063
[TBL] [Abstract][Full Text] [Related]
16. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
17. The interpretation of China national essential medicines list 2018.
Zuo W; Mei D; Sun W; Tang X; Niu Z; Gao D; Zhang B
Expert Rev Clin Pharmacol; 2020 Feb; 13(2):191-200. PubMed ID: 31914825
[No Abstract] [Full Text] [Related]
18. [Concordance between essential medicines lists and diabetes guidelines in Latin America and the CaribbeanConcordância entre as listas de medicamentos essenciais e diretrizes para diabetes na América Latina e no Caribe].
Urtasun MA; Dorati C; Cañás M; Bruzzone MS; Marín GH; Iusef Venturini N; Mordujovich Buschiazzo P
Rev Panam Salud Publica; 2024; 48():e3. PubMed ID: 38352034
[TBL] [Abstract][Full Text] [Related]
19. National adaptation and implementation of WHO Model List of Essential Medicines: A qualitative evidence synthesis.
Peacocke EF; Myhre SL; Foss HS; Gopinathan U
PLoS Med; 2022 Mar; 19(3):e1003944. PubMed ID: 35275938
[TBL] [Abstract][Full Text] [Related]
20. Essential medicines for cardiovascular diseases in India: Rapid appraisal of policies and processes at the subnational level.
Garg A; Murphy A; Krishna A; Sahoo SK; Huffman MD; Kishore SP; Shivashankar R
Natl Med J India; 2022; 35(6):357-363. PubMed ID: 37167513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]